We are live on ! Find out more
AXLA

Axcella Health Inc. Common Stock

Delisted

AXLA was delisted on the 22nd of November, 2023.

34 hedge funds and large institutions have $15.9M invested in Axcella Health Inc. Common Stock in 2022 Q4 according to their latest regulatory filings, with 8 funds opening new positions, 12 increasing their positions, 4 reducing their positions, and 6 closing their positions.

New
Increased
Maintained
Reduced
Closed

200% more repeat investments, than reductions

Existing positions increased: 12 | Existing positions reduced: 4

33% more first-time investments, than exits

New positions opened: 8 | Existing positions closed: 6

6% more funds holding

Funds holding: 3234 (+2)

50% less funds holding in top 10

Funds holding in top 10: 21 (-1)

73% less capital invested

Capital invested by funds: $58.3M → $15.9M (-$42.5M)

Holders
34
Holders Change
+2
Holders Change %
+6.25%
% of All Funds
0.55%
Holding in Top 10
1
Holding in Top 10 Change
-1
Holding in Top 10 Change %
-50%
% of All Funds
0.02%
New
8
Increased
12
Reduced
4
Closed
6
Calls
$1K
Puts
Net Calls
+$1K
Net Calls Change
+$1K
Name Holding Trade Value Shares
Change
Change in
Stake
FP
1
Flagship Pioneering
Massachusetts
$9.36M +$10.8M +415,351 +55%
Fidelity Investments
2
Fidelity Investments
Massachusetts
$3.61M +$3.25M +125,468 +40%
HP
3
Harbourvest Partners
Massachusetts
$2.04M +$1.9M +73,171 +42%
Vanguard Group
4
Vanguard Group
Pennsylvania
$252K +$466 +18 +0.1%
CCM
5
CAAS Capital Management
New York
$125K +$395K +15,246 New
BlackRock
6
BlackRock
New York
$97.5K +$1.17K +45 +0.4%
Geode Capital Management
7
Geode Capital Management
Massachusetts
$78K +$29.4K +1,134 +13%
BCM
8
Bridgeway Capital Management
Texas
$65.6K -$51.8K -2,000 -20%
ZIM
9
Zacks Investment Management
Illinois
$34.1K -$14.9K -574 -12%
Edgewood Management
10
Edgewood Management
Connecticut
$32.8K
Millennium Management
11
Millennium Management
New York
$32K +$101K +3,894 New
State Street
12
State Street
Massachusetts
$25.3K
Northern Trust
13
Northern Trust
Illinois
$16.8K +$14.8K +571 +39%
SC
14
Shay Capital
New York
$16.4K +$51.8K +2,000 New
Bank of New York Mellon
15
Bank of New York Mellon
New York
$14.3K
Renaissance Technologies
16
Renaissance Technologies
New York
$14K -$9.95K -384 -18%
Thrivent Financial for Lutherans
17
Thrivent Financial for Lutherans
Minnesota
$12K +$1.04K +40 +3%
Jane Street
18
Jane Street
New York
$10.5K +$33.3K +1,286 New
TRCT
19
Tower Research Capital (TRC)
New York
$9K +$17.2K +665 +156%
Susquehanna International Group
20
Susquehanna International Group
Pennsylvania
$7.63K -$32.7K -1,261 -58%
Charles Schwab
21
Charles Schwab
California
$5.98K
Citadel Advisors
22
Citadel Advisors
Florida
$5.84K +$6.76K +261 +58%
SG
23
StoneX Group
New York
$4.91K +$15.5K +600 New
Connor, Clark & Lunn Investment Management (CC&L)
24
Connor, Clark & Lunn Investment Management (CC&L)
British Columbia, Canada
$4.58K +$14.5K +559 New
TC
25
TownSquare Capital
Utah
$3.91K

AXLA Hedge Fund Activity: Q4 2022 in Review

34 of the 6,221 institutional investors tracked by Wall St. Rank reported a position in Axcella Health Inc. Common Stock (AXLA) for Q4 2022, worth a combined $15.9M — down 73% from $58.3M a quarter earlier.

Buyers outnumbered sellers: 8 funds opened new AXLA positions and 6 closed out — a net gain of 2 holders — while 12 added to existing stakes and 4 trimmed.

The largest buyer was Flagship Pioneering, adding an estimated $10.8M. The largest seller was Artal Group, exiting entirely with an estimated $1.22M sold.

  • 34 institutional investors held Axcella Health Inc. Common Stock (AXLA) as of Q4 2022, up from 32 in Q3 2022.
  • Funds reported $15.9M of Axcella Health Inc. Common Stock stock for Q4 2022, down 73% quarter-over-quarter.
  • 8 funds opened new Axcella Health Inc. Common Stock positions in Q4 2022 and 6 closed out, a net change of +2 holders.
  • The largest Axcella Health Inc. Common Stock buyer in Q4 2022 was Flagship Pioneering, an estimated $10.8M added.
  • The largest Axcella Health Inc. Common Stock seller in Q4 2022 was Artal Group, an estimated $1.22M sold.

Based on aggregated 13F filings for Q4 2022.